Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of ...(ies or which are owned by third parties ...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Shire Delivers Excellent Growth for the Year, With the new Product Portfolio Achieving Sales of $1 Billion
Date:2/19/2009
ies, or which are owned by third parties as indicated and referred to in this press release:
Product Active ingredient
ADDERALL(R) XR (mixed salts of a single-entity amphetamine)
AMIGAL(TM) (migalastat hydrochloride) (trademark of Amicus
Therapeutics ("Amicus"))
CALCICHEW(R) range (calcium carbonate with or without Vitamin D3)
CARBATROL(R) (carbamazepine - extended-release capsules)
DAYTRANA(R) (methylphenidate transdermal system)
DYNEPO(R) (epoetin delta) (trademark of Sanofi-Aventis)
ELAPRASE(R) (idursulfase)
EPIVIR (R) (lamivudine) (trademark of GlaxoSmithKline ("GSK"))
FIRAZYR(R) (icatibant)
FOSRENOL(R) (lanthanum carbonate)
INTUNIV(TM) (guanfacine - extended release)
LIALDA(R) (mesalamine)
METAZYM(TM) (arylsulfatase-A)
MEZAVANT(R) (mesalazine)
PENTASA(R) (mesalamine) (trademark of Ferring)
PLICERA(TM) (isofagomine tartrate) (trademark of Amicus)
RAZADYNE(R) (galantamine) (trademark of Johnson & Johnson
("J&J"))
RAZADYNE(R) ER (galantamine) (trademark of J&J)
REMINYL(R) (galantamine hydrobromide) (UK and Republic of
Ireland)
REMINYL(R) (galantamine) (trademark of J&J, excluding UK and
Republic of Ireland)
REMINYL XL(TM) (galantamine hydrobromide) (UK and Republic of
Ireland)
REMINYL XL(TM) (galantamine) (trademark of J&J, excluding UK and
Republic of Ireland)
REPLAGAL(R) (agalsidase alfa)
VYVANSE(R) (lisdexamfetamine dimesylate)
XAGRID(TM) (anagrelide hydrochloride)
ZEFFIX(R) (lamivudine) (trademark
'/>"/>
| SOURCE Shire Plc Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
2. Shire plc: Change to Directors Details
3. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
4. Shires New Product Portfolio Delivers Strong Quarterly Performance
5. Change of Name to Shire plc
6. Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
7. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
8. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
9. Shire Ltd.: Robin Buchanan to Step Down as Non-Executive Director on Completion of Term of Office
10. Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008
11. Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire
Post Your Comments:
(Date:12/15/2009)... 15 , ... Evaluate the Ability of,Cardiopoietic Cells to Restore Cardiac ... a leading Belgian biotechnology company specialising,in cell-based therapies ... it has completed, two months ahead of schedule,enrolment ... II/III trial of C-Cure, a,unique stem cell therapy ...
(Date:12/14/2009)... Dec. 14 Vermillion, Inc. (Pink ... announced William C. Wallen, Ph.D. Chief Scientific ... for IDEXX Laboratories, will be joining its ... bankruptcy plan. ,, "Bill brings more ... in diagnostics and biotechnology," said Gail Page, ...
(Date:12/14/2009)... ROCKAWAY, N.J., Dec. 14 The third ... Approach , published by the ... FDA-approved treatment for anthracycline extravasation.(1) Anthracyclines are ... idarubicin and epirubicin that have been used in ... the early 1970s.(2) ,, According to ...
(Date:12/14/2009)... SAN CARLOS, Calif., Dec. 14 Nektar ... Dennis Winger has been appointed to serve on ... highly-respected biopharmaceutical industry leader with over 35 years ... strategy. ,, "Dennis brings to Nektar extensive industry ... evolution," said Howard W. Robin, President and CEO ...
Breaking Biology Technology:Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5Dennis Winger Joins Nektar Therapeutics' Board of Directors 2Dennis Winger Joins Nektar Therapeutics' Board of Directors 3[0] Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure[0] Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors[0] Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation[0] Dennis Winger Joins Nektar Therapeutics' Board of Directors
... in Staff Since Start of Q4 2008 , - Evaluation ... and Resumes Board RoleSAN DIEGO, Jan. 5 ADVENTRX Pharmaceuticals, ... implemented a further reduction-in-force in an effort to extend its ... This follows a reduction implemented in October 2008. ...
... Jan. 5 In their latest book, You: Being,Beautiful ... (Free Press, 2008),co-authors Mehmet Oz, MD and Michael Roizen, ... nutritional heroes" that can "turbo-charge" those who need an,energy ... the body uses to,stimulate the production of adenosine triphosphate ...
... 5 Health Robotics today announced,that the ... made available the,first results of the SafeChemo ... The EU,s SafeChemo objectives were to scientifically ... and only automated,robotic system for the safe ...
Other Biology Technology:ADVENTRX Announces Further Cost-Cutting Measures 2ADVENTRX Announces Further Cost-Cutting Measures 3ADVENTRX Announces Further Cost-Cutting Measures 4ADVENTRX Announces Further Cost-Cutting Measures 5You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes' 2You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decade's 'Real Nutritional Heroes' 3Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project 2Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project 3Health Robotics Announces Results of the European Union-Sponsored SafeChemo Project 4(Date:12/14/2009)... (Dec. 14, 2009) -- Researchers at Rice University and ... nanoparticle that can be tracked in real time with ... them with a fluorescent dye and kills them with ... examples from a growing field called "theranostics" that develops ... in a single procedure. , The research is available ...
(Date:12/14/2009)... INDIANAPOLIS The most comprehensive study to date of ... regrow appendages may provide important clues to how similar ... at the School of Science at Indiana University-Purdue University ... the amputated limbs of axolotls, a type of salamander ... from any level of amputation, with the hope that ...
(Date:12/14/2009)... Technology Partners, a global software company that automates ... the Pharmaceutical industry, today announced the general availability ... data acquisition platform. The latest release enables quality ... manufacturing processes. ,, MODA 3.0 includes the ... Methods: Each test method in the MODA ...
Breaking Biology News(10 mins):Tracking new cancer-killing particles with MRI 2IUPUI researchers tackle protein mechanisms behind limb regeneration 2MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2The first gene encoded amphibian toxin isolated 9594 1A Public Option Means a Patient Option 54644 1Reliv International Launches Relivables 28TM 29 Product Family With New Skincare Products and Other Items 54642 1Reliv International Launches Relivables 28TM 29 Product Family With New Skincare Products and Other Items 54642 2Reliv International Launches Relivables 28TM 29 Product Family With New Skincare Products and Other Items 54642 3... disadvantage , Some viruses' ability to exploit the human ... both a blessing and curse, according to the findings ... Hopkins Bloomberg School of Public Health. The process is ... allow the dengue virus to grow more rapidly in ...
... of abuse decrease the generation of new neurons in ... process, called neurogenesis, had not been clear. , In ... of print publication of the November issue of the ... University of Saskatchewan show that a potent and synthetic ...
... cancer is a cruel disease. Left untreated, prostate cancer ... form fracture-prone tumors that are extremely painful. , ... prostate cancer die with metastatic disease in their bones. ... cancer cells set up housekeeping in bone tissue and ...
Other Biology News:Computer models aid understanding of antibody-dependent enhancement in spread of dengue fever 2Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors 2Prostate cancer uses Wnt signaling proteins to promote growth of bone tumors 3geminin, DNA replication inhibitor...
One-step, microplate or cuvet, colorimetric, linear detection range 0.1 mg/dL to 100 mg/dL. Procedure: 20 min....
biotin-4-fluorescein...
Agar, 5 lb. Bacteriological.Moisture: < 10%, ash: < 6.5%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |